Skip to main content
TipRanks
Go Ultimate75% OFF

Compare FACT II Acquisition Corp. Class A (FACT) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
FACTFACT II Acquisition Corp. Class A$10.82$263.16M56.204.39%―Unlock the FACT analyst price target with TipRanks PremiumFACTUnlock the FACT top-analyst price target with TipRanks Premium
NTWONewbury Street II Acquisition Corp Class A$10.87$100.34M61.804.77%―Unlock the NTWO analyst price target with TipRanks PremiumFACT vs NTWOUnlock the NTWO top-analyst price target with TipRanks Premium
JACSJackson Acquisition Co. II Class A$10.86$258.90M37.934.12%―Unlock the JACS analyst price target with TipRanks PremiumFACT vs JACSUnlock the JACS top-analyst price target with TipRanks Premium
DMAADrugs Made In America Acquisition Corp.$10.90$264.62M61.835.57%―Unlock the DMAA analyst price target with TipRanks PremiumFACT vs DMAAUnlock the DMAA top-analyst price target with TipRanks Premium
IACQIrenic Acquisition$9.95$258.15M―-0.05%―Unlock the IACQ analyst price target with TipRanks PremiumFACT vs IACQUnlock the IACQ top-analyst price target with TipRanks Premium
CAESCantor Equity Partners VII, Inc. Class A$10.03$319.46M―-0.79%―Unlock the CAES analyst price target with TipRanks PremiumFACT vs CAESUnlock the CAES top-analyst price target with TipRanks Premium

Performance Comparison

-2%0%3%5%8%10%13%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
FACTFACT II Acquisition Corp. Class A10.820.484.64%
NTWONewbury Street II Acquisition Corp Class A10.870.474.52%
JACSJackson Acquisition Co. II Class A10.860.424.02%
DMAADrugs Made In America Acquisition Corp.10.900.585.62%
IACQIrenic Acquisition9.95-0.00-0.05%
CAESCantor Equity Partners VII, Inc. Class A10.03-0.08-0.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts